PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7678807-5	1993	Moreover, amino acid substitutions around phosphotyrosine in the peptides src(412-418), src(414-418) and abl-(390-397) deeply influence the dephosphorylation efficiency.	lauric acid	105-108	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	74-77	
26102035-0	2015	1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling.	lauric acid	27-30	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	106-109	
26102035-5	2015	For the mechanism investigations, we found that ABL largely inhibited VEGF-mediated activation of Src kinase and focal adhesion kinase (FAK) in HUVECs.	lauric acid	48-51	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	98-101	
26102035-6	2015	Furthermore, treatment of A549 NSCLC cells with ABL resulted in cell growth inhibition and Src-FAK in-activation.	lauric acid	48-51	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	91-94	
26102035-9	2015	Taken together, our findings suggest that ABL suppresses angiogenesis and lung cancer cell growth possibly via regulating the VEGFR-Src-FAK signaling.	lauric acid	42-45	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	132-135	
16441434-0	2006	Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus.	lauric acid	0-3	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	22-25